Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
New submental and under-eye applicators expand its non-invasive facial rejuvenation capabilities.
The collagen-based dermal regeneration template is designed for improved patient outcomes in the treatment of full-thickness wounds.